Dr. Vikas Sharotri, MD

Dr. Sharotri practices at EvergreenHealth Medical Center Kirkland in Kirkland, Washington.

Dr. Sharotri's NPI, 1487870127, was assigned on April 18, 2007. Dr. Sharotri holds Washington license MD60485447.

Dr. Sharotri's primary practice is EvergreenHealth Medical Center Kirkland, at 12040 Ne 128th St, Kirkland, WA 98034 in King County. The practice phone is (425) 899-1000.

Dr. Sharotri's primary practice is EvergreenHealth Medical Center Kirkland in Kirkland, Washington. Dr. Sharotri is also affiliated with EvergreenHealth Medical Center. The medical group on file is Booth Gardner Parkinson's Care Center. Dmand AI also links Dr. Sharotri to 2 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharotri practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sharotri's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Sharotri's licenses on file in 2 states: Washington and Iowa.

CMS data shows 1,805 Medicare services from Dr. Sharotri across 24 procedure codes in 2024, for 761 Medicare patients. Medicare paid $79,950 for them.

CMS counts 761 Medicare patients who saw Dr. Sharotri in 2024. The largest group is 75 to 84, with 295 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharotri's median patient age at 73, with 46% women.

In 2024, Dr. Sharotri wrote 4,691 Medicare Part D claims for 533 patients. 89% of them were for generic drugs. CMS names the drug for 4,468 of them, across 45 drugs with 11 or more claims each, at $640,630 in total drug cost. In 2023, CMS named 3,190 claims across 39 drugs.

Dr. Sharotri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sharotri as offering telehealth.

Dmand AI links 2 papers to Dr. Sharotri in 2012. 2012 was the busiest year, with 2. The most frequent topics are HEK293 Cells and Ion Transport. Dr. Sharotri has published most often in J Biol Chem. Dr. Sharotri's most frequent co-authors are Denice M. Hodgson-Zingman, MD, Ruifeng Zhou, MD and Leonid Vladimir Zingman, MD.

CMS Open Payments shows 3 general payments to Dr. Sharotri from 3 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 71% of the total. Sanofi and Genzyme US Companies paid the most, $17.